Stock 600381 QINGHAI SPRING MEDICINAL RESOURCES TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Qinghai Spring Medicinal Resources Technology Co., Ltd. Share Price

Equities

600381

CNE0000017W0

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 26/04/2024 am IST 		5-day change 1st Jan Change
4.29 CNY +0.70% Intraday chart for Qinghai Spring Medicinal Resources Technology Co., Ltd. +0.94% -44.50%
19/04 Qinghai Spring Medicinal Resources Technology Plans Shares Buyback of Up to 50 Million Yuan MT
19/04 Qinghai Spring Medicinal Resources Technology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares. CI

Financials

Sales 2021 128M 17.63M 1.47B Sales 2022 160M 22.11M 1.84B Capitalization 7.23B 997M 83.16B
Net income 2021 -249M -34.36M -2.87B Net income 2022 -288M -39.75M -3.31B EV / Sales 2021 37.2 x
Net cash position 2021 198M 27.39M 2.28B Net cash position 2022 164M 22.7M 1.89B EV / Sales 2022 44.1 x
P/E ratio 2021
-20.1 x
P/E ratio 2022
-25.1 x
Employees 175
Yield 2021 *
-
Yield 2022
-
Free-Float 55.91%
More Fundamentals * Assessed data

Chart Qinghai Spring Medicinal Resources Technology Co., Ltd.

Dynamic Chart

Latest news about Qinghai Spring Medicinal Resources Technology Co., Ltd.

Qinghai Spring Medicinal Resources Technology Plans Shares Buyback of Up to 50 Million Yuan MT
Qinghai Spring Medicinal Resources Technology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares. CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. authorizes a Buyback Plan. CI
Qinghai Spring Medicinal Resources Probed Over Misleading Ad for Rice Wine MT
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd.(XSSC:600381) added to S&P Global BMI Index CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Beijing Life Capital Management Co., Ltd. completed the acquisition of a 5% stake in Qinghai Spring Medicinal Resources Technology Co., Ltd. from Tibet Rongen Technology Co., Ltd. CI
Beijing Life Capital Management Co., Ltd. signed the share transfer agreement to acquire a 5% stake in Qinghai Spring Medicinal Resources Technology Co., Ltd. from Tibet Rongen Technology Co., Ltd. for approximately CNY 200 million. CI
More news

Press releases Qinghai Spring Medicinal Resources Technology Co., Ltd.

The 'Duos-activation' Healthy Brewing Theory of Qinghai Spring's Tinghua Liquor Gains International Recognition, FDA and TTB Have Authorized Its Overseas Product to Be Sold in the United States BU
WIPO Published an International Patent Application From Qinghai Spring's Tinghua Liquor: Will Improve People's Relationship With Alcohol and Reshape Distilled Spirits' Value Proposition BU
More press releases

Quotes and Performance

1 day+0.70%
1 week+0.94%
Current month-19.21%
1 month-18.90%
3 months-39.75%
6 months-41.55%
Current year-44.50%
More quotes

Highs and lows

1 week
4.05
Extreme 4.05
4.39
1 month
3.82
Extreme 3.82
5.37
Current year
3.82
Extreme 3.82
8.28
1 year
3.82
Extreme 3.82
10.09
3 years
3.82
Extreme 3.82
20.67
5 years
3.82
Extreme 3.82
20.67
10 years
3.82
Extreme 3.82
50.09
More quotes

Managers and Directors - Qinghai Spring Medicinal Resources Technology Co., Ltd.

Managers TitleAgeSince
Xue Feng Zhang CEO
 Chief Executive Officer 55 30/15/30
Lin Wang DFI
 Director of Finance/CFO 55 18/18/18
Tie Peng Yao BRD
 Director/Board Member 71 15/15/15
Members of the board TitleAgeSince
Xue Min Gao BRD
 Director/Board Member 86 04/20/04
Rong Xiao BRD
 Director/Board Member 54 -
Xue Feng Zhang CEO
 Chief Executive Officer 55 30/15/30
More insiders

ETFs positioned on Qinghai Spring Medicinal Resources Technology Co., Ltd.

Name Weight AuM 1st Jan change Investor Rating
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD ETF Unlimited HFND Multi-Strategy Return Tracker ETF - USD
0.00% 34 M€ +2.14% -
More ETFs positioned on Qinghai Spring Medicinal Resources Technology Co., Ltd.

Quotes

Date Price Change Volume
26/24/26 4.29 +0.70% 10,560,200
25/24/25 4.26 +0.24% 8,637,828
24/24/24 4.25 +1.92% 9,923,224
23/24/23 4.17 +0.48% 9,989,500
22/24/22 4.15 -2.35% 13,223,610

End-of-day quote Shanghai S.E., April 26, 2024

More quotes

Company Profile

QINGHAI SPRING MEDICINAL RESOURCES TECHNOLOGY CO.,LTD is a China-based company that principally engaged in the integrated development, utilization, production, sales and consulting services of the natural advantageous resources on the Qinghai-Tibet plateau, as well as the development and utilization of other biological resources. The Company’s main products are the cordyceps sinensis series products under Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis and raw cordyceps sinensis. The Company’s subsidiary is Qinghai Spring Pharmaceutical Resource Utilization Co Ltd.
Sector
Pharmaceuticals
Calendar
30/04/2024 - Q4 2023 Earnings Release
More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
QINGHAI SPRING MEDICINAL RESOURCES TECHNOLOGY CO., LTD. Stock Qinghai Spring Medicinal Resources Technology Co., Ltd.
-44.50% 348M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+35.04% 5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-15.13% 4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-9.75% 3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+2.14% 3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-6.82% 2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+47.87% 1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-7.89% 1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+0.09% 1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-12.97% 1.53B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. 600381 Stock